Garcia Santiago, Elmariah Sammy, Cubeddu Robert J, Zahr Firas, Eleid Mackram F, Kodali Susheel K, Seshiah Puvi, Sharma Rahul, Lim D Scott
The Christ Hospital Health Network, Cincinnati, Ohio, USA.
University of California, San Francisco, California, USA.
Struct Heart. 2023 Nov 18;8(1):100234. doi: 10.1016/j.shj.2023.100234. eCollection 2024 Jan.
In 2022, the Food and Drug Administration approved a second mitral transcatheter edge-to-edge repair device for the treatment of primary mitral regurgitation (PASCAL Precision Transcatheter Valve Repair System, Edwards Lifesciences, Irvine, CA). The PASCAL Precision system consists of a guide sheath, implant system, and accessories. The implant system consists of a steerable catheter, an implant catheter, and the implant (PASCAL or PASCAL Ace). The guide sheath and steerable catheter move and flex independently from each other and are not keyed, allowing for freedom of rotation in three dimensions. This manuscript provides an overview of the PASCAL Precision system and describes the basic and advanced steering maneuvers to facilitate effective and safe mitral transcatheter edge-to-edge repair.
2022年，美国食品药品监督管理局批准了第二种用于治疗原发性二尖瓣反流的经导管二尖瓣缘对缘修复装置（PASCAL Precision经导管瓣膜修复系统，爱德华生命科学公司，加利福尼亚州尔湾）。PASCAL Precision系统由引导鞘管、植入系统和附件组成。植入系统由可操纵导管、植入导管和植入物（PASCAL或PASCAL Ace）组成。引导鞘管和可操纵导管彼此独立移动和弯曲，且无锁定装置，可在三维空间自由旋转。本文概述了PASCAL Precision系统，并描述了基本和高级的操纵技巧，以促进有效且安全的经导管二尖瓣缘对缘修复。
